drug
incobotulinumtoxinA
Marketedupdated 3mo agoby Merz Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying incobotulinumtoxinA
- phase3Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
- phase2A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
- phase3A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
- phase2Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study
- phase3A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
- phase3Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
- phase4Xeomin® and Gait Related Mobility After Stroke
- phase1Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 41m ago
Found something off?
comments(0)
5-min edit window · permanent after that